-
1.
公开(公告)号:EP3011030B1
公开(公告)日:2023-11-08
申请号:EP14734709.0
申请日:2014-06-10
发明人: ZHANG, Feng , HSU, Patrick , LIN, Chie-yu , RAN, Fei
-
公开(公告)号:EP3615683B1
公开(公告)日:2022-10-12
申请号:EP18724679.8
申请日:2018-04-26
发明人: XIN, Xiaofeng , NICOL, Robert
IPC分类号: C12Q1/6853 , C12Q1/6869
-
公开(公告)号:EP3971215A2
公开(公告)日:2022-03-23
申请号:EP21181903.2
申请日:2015-12-15
发明人: XIA, Xiaobing , DING, Hanghai , JIANG, Shisong
摘要: Provided are an artificial multi-antigen fusion protein and a preparation method thereof. The fusion protein can effectively stimulate CD8+T and CD4+ T cell immunities, and can be applied to immunodiagnostics or serve as a prophylactic or therapeutic vaccine.
-
4.
公开(公告)号:EP3959261A1
公开(公告)日:2022-03-02
申请号:EP20796179.8
申请日:2020-04-27
-
公开(公告)号:EP3946597A1
公开(公告)日:2022-02-09
申请号:EP20718823.6
申请日:2020-04-03
申请人: Galderma Holding SA
IPC分类号: A61P17/10 , A61K8/38 , A61Q19/00 , C07C409/34 , A61K31/216
-
公开(公告)号:EP3872170A1
公开(公告)日:2021-09-01
申请号:EP20170251.1
申请日:2020-04-17
发明人: KENNEDY, Eileen , KORTHOLT, Arjan
IPC分类号: C12N9/12 , C07K14/435 , A61K38/10
摘要: The present disclosure describes synthetic polypeptides for the inhibition or modulation of the activity of leucine-rich repeat kinase 2 (LRRK2) along with methods of using the same in the treatment of medical conditions, for example neurological diseases or disorders.
-
7.
公开(公告)号:EP3852780A1
公开(公告)日:2021-07-28
申请号:EP19863073.3
申请日:2019-09-19
申请人: Cell Machines, Inc.
发明人: KELLY, James , PERRYMAN, David G.
IPC分类号: A61K38/00 , A61K38/37 , C07K14/755 , C07K19/00
-
公开(公告)号:EP3844506A1
公开(公告)日:2021-07-07
申请号:EP19854166.6
申请日:2019-08-27
申请人: Nanjing University
发明人: HUANG, Shuo , CAO, Jiao
-
公开(公告)号:EP3830580A1
公开(公告)日:2021-06-09
申请号:EP19843390.6
申请日:2019-07-30
发明人: HUGHES, Thomas , TEWSON, Paul
IPC分类号: G01N33/566 , G01N33/53 , G01N33/50 , C07K14/00 , G01N33/542
-
公开(公告)号:EP3823589A1
公开(公告)日:2021-05-26
申请号:EP19756447.9
申请日:2019-07-18
-
-
-
-
-
-
-
-
-